Effects of CD28 Costimulation on Long-Term Proliferation of CD4+ T Cells in the Absence of Exogenous Feeder Cells

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 5921-5930

  Levine, Bruce L ^a,d   Bernstein, Wendy B ^b   Connors, Mark ^c   Craighead, Nancy ^d   Lindsten, Tullia ^e   Thompson, Craig B ^e   June, Carl H ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 2; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL CULTURE; CELL DIVISION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIVISION; CELLS, CULTURED; CLONE CELLS; CYTOKINES; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS;

EID: 0031573612     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 13:74.
2. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
3. Jenkins, M. K., and J. G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:361.
4. Schwanz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
5. 1. Immunity 3:87.
6. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
7. + T cells. Science 276:273.
8. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
9. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
10. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
11. van der Merwe, P. A., D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis. 1997. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:393.
12. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
13. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
14. Bluestone, J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989.
15. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985.
16. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
17. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.
18. McLean, A. R., and C. A. Michie. 1995. In vivo estimates of division and death rates of human T lymphocytes. Proc. Natl. Acad. Sci. USA 92:3707.
19. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272:1939.
20. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7:4472.
21. Cochet, M., C. Pannetier, A. Regnault, S. Darche, C. Leclerc, and P. Kourilsky. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639.
22. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90:4319.
23. Pannetier, C., J. Even, and P. Kourilsky. 1995. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today 16:176.
24. Genevee, C., A. Diu, J. Nierat, A. Caignard, P. Y. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotidc primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261.
25. Riley, J. L., R. G. Carroll, B. L. Levine, W Bernstein, D. C. St. Louis, O. S. Weislow, and C. H. June. 1997. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545.
26. Miyatake, S., M. Sakuma, and T. Saito. 1997. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor Eur. J. Immunol. 27:1816.
27. + cells delineated by BB27 mAb. Int. Immunol. 6:423.
28. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:891.
29. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1995. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc. Natl. Acad. Sci. USA 92:11091.
30. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat. Med. 3: 533.
31. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
32. McHugh, S., J. Deighton, I. Rifkin, and P. Ewan. 1996. Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur. J. Immunol. 26:1260.
33. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121.
34. + cells. Eur. J. Immunol. 25:587.
35. Riddell, S. R., and P. D. Greenberg. 1990. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128:189.
36. Sunder-Plassman, R., H. Breitneder, K. Zimmermann, D. Strunk, O. Majdic, W. Knapp, and W. Holter. 1996. Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation. Blood 87: 5179.
37. + T cells. Eur. J. Immunol. 23:608.
38. + T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29:601.
39. + lymphocytes during HIV infection. Scand. J. Immunol. 40:485.
40. Borthwick, N. J., M. Bofill, W. M. Gombert, A. N. Akbar, E. Medina, K. Sagawa, M. C. Lipman, M. A. Johnson, and G. Janossy. 1994. Lymphocyte activation in HIV1 infection. II. Functional defects of CD28T cells. AIDS 8:431.
41. + T lymphocytes during HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:245.
42. + T cells from HIV-infected persons. J. Immunol. 153:412.
43. Lake, R. A., R. E. O'Hehir, A. Verhoef, and J. R. Lamb. 1993. CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptide. Int. Immunol. 5:461.
44. + T cells. J. Immunol. 158:1551.
45. Geppert, T. D., and P. E. Lipsky. 1988. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3: regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest. 81:1497.
46. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858.
47. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032.
48. Smith, K. A., S. Gillis, P. E. Baker, D. McKenzie, and F. W. Ruscetti. 1979. T-cell growth factor-mediated T-cell proliferation. Ann. NY Acad. Sci. 332:423.
49. Gullberg, M. and K. A. Smith. 1986. Regulation of T cell autocrine growth: T4+ cells become refractory to interleukin 2. J. Exp. Med. 163:270.
50. Perillo, N. L., R. L. Walford, M. A. Newman, and R. B. Effros. 1989. Human T lymphocytes possess a limited in vitro life span. Exp. Gerontol. 24:177.
51. + T lymphocytes. Blood 85:3213.
52. Adibzadeh, M., H. Pohla, A. Rehbein, and G. Pawelec. 1995. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech. Ageing Der. 83:171.
53. Adibzadeh, M., E. Mariani, C. Bartoloni, I. Beckman, G. Ligthart, E. Remarque, S. Shall, R. Solana, G. M. Taylor, Y. Barnett, and G. Pawelec. 1996. Lifespans of T lymphocytes. Mech. Ageing Dev. 91:145.
54. Weng, N. P., B. L. Levine, C. H. June, and R. J. Hodes. 1996. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:2471.
55. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
56. Liu, Y., and C. A. Janeway, Jr. 1992. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. Proc. Natl. Acad. Sci. USA 89:3845.
57. Engwerda, C. R., B. S. Handwerger, and B. S. Fox. 1994. Aged T cells are hyporesponsive to costimulation mediated by CD28. J. Immunol. 152:3740.
58. + T cell clones in elderly humans. J. Immunol. 158:4493.
59. + T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143.